E18 What’s new in industry and science? Short oral presentations Part 3
Wednesday 13 September 2017
09:00-11:30
COEX Convention & Exhibition Center : Grand Ballroom 101 + 102 3 hours
Organised by the FIP Boards of Pharmaceutical Sciences and Pharmaceutical Practice
Chairs: Gabrielle Wiederkehr (Access Consulting, Switzerland)
Programme
09:00 – 09:05
1) Introduction by the Chair
09:05 – 09:30
2) Epigallocatechin-3-gallate prevents acute gout by suppressing nlrp3 inflammasome activation
Hye Eun Lee (Republic of Korea)
09:30 – 09:55
3) Alteration of serum glutamate level in male adults with drug resistant epilepsy
Wei Wang (China)
09:55 – 10:20
4) Association between abcc8 rs757110 (ser1369ala) gene polymorphism and sulphonylurea response in malaysian type 2 diabetes patients
Navin Kumar Loganadan (Malaysia)
10:20 – 10:40 Coffee/tea break
10:40 – 11:05
5) Implementing pharmacogenomics in Europe: Design and implementation strategy of the ubiquitous pharmacogenomics consortium
Inge Holsappel (Netherlands)
11:05 – 11:30
6) Q & A, discussion and conclusion by the Chair